Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Gefarc 250mg Tablet
Manufacturer/Marketed By : DELARC PHARMACEUTICALS
$23.64 $3.99
Gefarc 250mg Tablet is an antineoplastic drug belonging to the tyrosine kinase inhibitors, containing the active ingredient Gefitinib. It is used to treat non-small cell lung cancer. Non-small cell lung...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
GEFITINIB
Active Pharmaceutical Ingredient
Gefarc 250mg Tablet
$23.64
$3.99
Gefarc 250mg Tablet is an antineoplastic drug belonging to the tyrosine kinase inhibitors, containing the active ingredient Gefitinib. It is used to treat non-small cell lung cancer. Non-small cell lung cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner in the tissues of the lung. It is used in patients where the NSCLC cancer has spread to other parts of the body, who have certain types of abnormal epidermal growth factor (EGFR) genes, and patients who have not received any cancer treatment. Some formulations of Gefarc 250mg Tablet may contain lactose as an inactive ingredient in which the body is unable to digest lactose, a sugar found in milk and dairy products. It can cause symptoms such as bloating and abdominal pain. If you have lactose intolerance, inform your doctor before starting this therapy. Talk with your healthcare provider if you have kidney or liver disease, vision problems, lung problems or are taking any blood thinner like warfarin. Your healthcare provider will check regular blood tests to prevent complications. Avoid consuming alcohol as it may cause dizziness. Consult your doctor before using this medication if you are pregnant or plan to have a baby. Gefarc 250mg Tablet are unsafe to use during pregnancy as they cause harm to an unborn fetus. Your health care practitioner will conduct a pregnancy test before you start treatment with Gefarc 250mg Tablet. Avoid breastfeeding your baby while on the treatment as it is unknown if Gefarc 250mg Tablet passes into breast milk.
Active Pharmaceutical Ingredient
Uses
• Non-small cell lung cancer.
Benefits
It is an anilinoquinazoline derivative which interacts with a kinase inhibitor that inhibits an abnormal protein called the epidermal growth factor receptor (EGFR). This helps to slow or stop the growth of cancer cells and reduce the size of tumours in patients with NSCLC.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Common Side Effects
• Diarrhea
• Nausea
• Vomiting
• Loss of appetite
• weakness
• Red or sore mouth
• increased liver enzymes
• itchy or cracked skin
• dry mouth
• Red or itchy eyes
• nail problems
• hair loss
• fever
• Blood in the urine and a burning sensation while urinating
How To Use
Gefarc 250mg Tablet is available as a tablet to be taken with or without food, as directed by your healthcare provider. The usual recommended dosage is 250 mg tablet once daily. Avoid crushing, opening, or dissolving the tablet; swallow it whole with a glass of water. Take the Gefarc 250mg Tablet at the same time every day.
Safety Advice
• Breast Feeding: It is unsafe to breastfeed during the treatment with this Gefarc 250mg Tablet because it may cause harm to the baby. Please consult your doctor before breastfeeding.
• Alcohol: It is unknown whether consuming alcohol interacts with the Gefarc 250mg Tablet. Please consult your doctor for more advice. Consuming alcohol may affect the effectiveness of bendamustine. Stop consuming alcohol if you are taking this medicine.
• Liver: It is unknown whether Gefarc 250mg Tablet can be used for patients with liver disorders. Inform your physician if you have any liver problems before starting the treatment.
• Lungs: It is unknown whether Gefarc 250mg Tablet can be used for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
• Driving: It is unsafe to drive vehicles or operate heavy machinery after taking the Gefarc 250mg Tablet because it contains a small amount of alcohol which may cause dizziness and impair your concentration.
• Pregnancy: It is unsafe to use during pregnancy whether Gefarc 250mg Tablet can be taken during pregnancy. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.